These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Makkar KM, Sanoski CA, Spinler SA. Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795 [Abstract] [Full Text] [Related]
7. Cellular basis for therapeutic choices in heart failure. Opie LH. Circulation; 2004 Oct 26; 110(17):2559-61. PubMed ID: 15505109 [No Abstract] [Full Text] [Related]
8. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS. Am J Med; 2007 Dec 26; 120(12):1090.e1-8. PubMed ID: 18060931 [Abstract] [Full Text] [Related]
9. The HF epidemic: the need for new treatment strategies. Carson PE. J Renin Angiotensin Aldosterone Syst; 2000 Jun 26; 1(2 Suppl):S32-4. PubMed ID: 17199218 [Abstract] [Full Text] [Related]
10. [Pharmacological therapy of chronic heart failure in the elderly]. Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G. Ital Heart J; 2004 Dec 26; 5 Suppl 10():37S-51S. PubMed ID: 15712511 [Abstract] [Full Text] [Related]
11. Angiotensin II receptor blockers in chronic heart failure--not as ELITE as expected! Farquharson CA, Struthers AD. J Renin Angiotensin Aldosterone Syst; 2000 Mar 26; 1(1):21-2. PubMed ID: 11967790 [Abstract] [Full Text] [Related]
12. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure. Shah NC, Pringle S, Struthers A. J Renin Angiotensin Aldosterone Syst; 2006 Mar 26; 7(1):20-30. PubMed ID: 17083070 [Abstract] [Full Text] [Related]
14. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers]. Kubota T, Takeshita A. Nihon Rinsho; 2003 May 26; 61(5):801-6. PubMed ID: 12755006 [Abstract] [Full Text] [Related]
15. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials. Volpe M, Tocci G, Sciarretta S, Verdecchia P, Trimarco B, Mancia G. J Hypertens; 2009 May 26; 27(5):941-6. PubMed ID: 19381108 [Abstract] [Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. Vijan SG. J Indian Med Assoc; 2009 Mar 26; 107(3):178-82. PubMed ID: 19810392 [Abstract] [Full Text] [Related]